Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
12 11 Search
2025
Monensin Inhibits Triple-Negative Breast Cancer in Mice by a Na+-Dependent Cytotoxic Action Unrelated to Cytostatic Effects
Cells
2024
Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways
Breast Cancer Research and Treatment
2024
Golgi apparatus targeted therapy in cancer: Are we there yet?
Life Sciences
2024
Inhibition of Wnt/β-catenin signaling by monensin in cervical cancer
The Korean Journal of Physiology & Pharmacology
2023
Monensin synergizes with chemotherapy in uveal melanoma through suppressing RhoA
Immunopharmacology and Immunotoxicology
2022
Bioactive Microbial Metabolites in Cancer Therapeutics: Mining, Repurposing, and Their Molecular Targets
Current Microbiology
2022
Monensin Inhibits Anaplastic Thyroid Cancer via Disrupting Mitochondrial Respiration and AMPK/mTOR Signaling
Anti-Cancer Agents in Medicinal Chemistry
2021
Monensin suppresses cell proliferation and invasion in ovarian cancer by enhancing MEK1 SUMOylation
Experimental and Therapeutic Medicine
2020
Study on in vitro Toxicity of Biometal(II) Monensinates Against Rat Zajdela Liver Tumour
Chemistry-Didactics-Ecology-Metrology
2020
Monensin inhibits glioblastoma angiogenesis via targeting multiple growth factor receptor signaling
Biochemical and Biophysical Research Communications
Additional cited-by details will be shown when available from Crossref